George Yancopoulos, President and Chief Scientific at REGENERON PHARMACEUTICALS, INC. (REGN), sold 236,246 shares at $420.17 ($99.3M) on 2020-02-24, disclosed to the SEC on 2020-02-25.
Open-market sale of $99.3M REGN by President and Chief Scientific. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $420.17 | 118,123 | $49.6M | 50.0% |
| 2 | $420.17 | 118,123 | $49.6M | 50.0% |
| Total | $420.17 avg | 236,246 | $99.3M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |